Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Giuseppe Danilo Vighi"'
Autor:
Giada Crescioli, Alessandra Bettiol, Roberto Bonaiuti, Marco Tuccori, Marco Rossi, Annalisa Capuano, Silvia Pagani, Giulia Spada, Mauro Venegoni, Giuseppe Danilo Vighi, Guido Mannaioni, Alfredo Vannacci, Niccolò Lombardi, MEREAFaPS Study group
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: There is a significant gap in knowledge addressing cardiovascular (CV) medications safety in elderly. In this context, our purposes were to define clinical and pharmacological characteristics of outpatients’ adverse drug events (ADEs) r
Externí odkaz:
https://doaj.org/article/626697ecfa0a4a7b8aa3ad5bb6dae11a
Autor:
Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Marco Tuccori, Annalisa Capuano, Roberto Bonaiuti, Alessandro Mugelli, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, the MEREAFaPS Study group, Maria Luisa Aiezza, Daria Bettoni, Corrado Blandizzi, Valentina Borsi, Errica Cecchi, Irma Convertino, Martina Del Lungo, Cristina Di Mauro, Gabriella Farina, Sara Ferraro, Annamaria Fucile, Elena Galfrascoli, Elisabetta Geninatti, Linda Giovannetti, Luca Leonardi, Rosa Liccardo, Anna Marra, Eleonora Marrazzo, Giovanna Monina, Silvia Pagani, Maria Parrilli, Concetta Rafaniello, Francesco Rossi, Marco Rossi, Stefania Rostan, Marco Ruocco, Marita Sironi, Giulia Spada, Liberata Sportiello, Giuditta Violetta Vighi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundAdverse drug event (ADEs) are a significant cause of emergency department (ED) visits and consequent hospitalization. Preventing ADEs and their related ED visits in outpatients remains a public health safety challenge. In this context, the
Externí odkaz:
https://doaj.org/article/9018384e433b4a9bad78df6444709026
Autor:
Giada Crescioli, Ennio Boscia, Alessandra Bettiol, Silvia Pagani, Giulia Spada, Giuditta Violetta Vighi, Roberto Bonaiuti, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Niccolò Lombardi, on behalf of the MEREAFaPS Study Group
Publikováno v:
Pharmaceuticals, Vol 14, Iss 7, p 678 (2021)
This post hoc analysis of an Italian active pharmacovigilance study describes pharmacological differences of ADEs leading to emergency department (ED) visits and hospitalization in women and men. During the study period (January 2007–December 2018)
Externí odkaz:
https://doaj.org/article/1cc4b65143aa453fa946a238995f6fd2
Autor:
Maria L. La Targia, Giulia Quaresmini, Giuliana Muti, Anna Maria Pelizzari, Maria C. Vilardo, Eraldo Lanzi, Giuseppe Danilo Vighi, Nicola Stefano Fracchiolla, Niccolò Frungillo, M.C. Pasquini, Roberta Gaiardoni, Agostino Cortelezzi, Maurizio Bonfichi, Alessandra Ragazzi, Silvia Artuso, Dario Consonni, Federica Bocchio, Lucia Prestini, Claudia Bacci, Simona Sammassimo, Giacomo Berini, Daniele Boghi, Alessia Pastore, Alma Lisa Rivolta, Giuseppe Gritti, Massimo Magagnoli, Simone Voltolini, Elisa De Rosa, Paola Tozzi, Consuelo Corti, Livio Gargantini
Publikováno v:
Hematological oncology. 36(1)
Adverse drug reactions (ADRs) reduce patients' quality of life, increase mortality and morbidity, and have a negative economic impact on healthcare systems. Nevertheless, the importance of ADR reporting is often underestimated. The project "FarmaREL"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c692a28bd843e8629325b1e22135c95e
https://pubmed.ncbi.nlm.nih.gov/28771763
https://pubmed.ncbi.nlm.nih.gov/28771763
Autor:
Janouk, Diphoorn, Simone, Cazzaniga, Chiara, Gamba, Jan, Schroeder, Antonella, Citterio, Alma Lisa, Rivolta, Giuseppe Danilo, Vighi, Luigi, Naldi, A, Malesci
Publikováno v:
Pharmacoepidemiology and drug safety. 25(2)
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe cutaneous adverse drug reactions. We assessed incidence, drug exposure and mortality, analysing data obtained from the Lombardy Registry of Severe Cutaneous React
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4351dd003ceaa7be6a43d4cde75c1421
https://pubmed.ncbi.nlm.nih.gov/26687641
https://pubmed.ncbi.nlm.nih.gov/26687641
Autor:
Valentino Conti, Valentina Perrone, Sonia Radice, Mauro Venegoni, Lucia Prestini, Luca Degli Esposti, Giuseppe Danilo Vighi, Emilio Clementi, Stefania Scotto, Diego Sangiorgi
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Valentina Perrone,1,* Valentino Conti,2,* Mauro Venegoni,2 Stefania Scotto,2 Luca Degli Esposti,3 Diego Sangiorgi,3 Lucia Prestini,4 Sonia Radice,1 Emilio Clementi,5,6 Giuseppe Vighi,2,4 1Unit of Clinical Pharmacology, Department of Biomedical and Cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9fac43f1162e60a8758fde060c75c9a
https://www.dovepress.com/seriousness-preventability-and-burden-impact-of-reported-adverse-drug--peer-reviewed-article-CEOR
https://www.dovepress.com/seriousness-preventability-and-burden-impact-of-reported-adverse-drug--peer-reviewed-article-CEOR